Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/10/037639
CTRI/2021/10/037639
Not Yet Recruiting
Phase 3

Evaluation of bone density, horizontal bone thickness and vertical bone height changes in patientsrehabilitated with basal/cortical implants: A cone beam computed tomography study.

Dr Sayana Nazrine0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Sayana Nazrine
Status
Not Yet Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sayana Nazrine

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of age between 25\-60 with hopeless tooth/teeth.
  • •2\.Partially edentulous patients.
  • •3\.Medically fit patients.
  • •4\.Patients with failed implants/re\-implant procedures.
  • •5\.Willingness to provide informed consent.

Exclusion Criteria

  • •1\.With previous history of chemotherapy or radiotherapy.
  • •2\.Patients with smoking habit.
  • •3\.Under the administration of bisphosphonates.
  • •4\.Diagnosed case of aggressive periodontitis.
  • •5\.Suffering from a known psychological problem due to difficulty in maintaining oral hygiene.
  • •6\.Patients with uncontrolled diabetes.
  • •7\.Recent history of myocardial infarction or cerebrovascular accident.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Comparing bone strength and implant stability in people with high cholesterol levelsHealth Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
CTRI/2024/07/070551Datta Meghe Institute of Higher Education and Research
Not Yet Recruiting
Phase 2
Effect of 1% Metformin gel on bone density.
CTRI/2024/05/067922Dr Tushar Mohata
Recruiting
N/A
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritis
DRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60
Completed
N/A
Evaluation of bone mineral density and bone metabolism during treatment with januskinaseinhibitors baricitinib or tofacintib in patients with rheumatoid arthritisM05.80M06.00
DRKS00020780Campus Kerckhoff der Justus Liebig Universität Giessen, Abteiliung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin89
Not Yet Recruiting
Phase 1
effect of drug on implant and bone density
CTRI/2019/02/017827keerthi pola